Search Results For ''

  • Alterity Therapeutics moves neuroprotective drug to Phase 2 trials

    Seven to ten years. That’s how long someone diagnosed with multiple system atrophy (MSA) has to live from when symptoms first appear. The progressive disease results in the gradual functional decline of the body’s involuntary functions such as blood pressure, breathing, bladder function and motor control. Often confused with Parkinson’s which is characterised by the

    Read More
    Public
  • Bubs to the rescue as special operation gets underway

    Shareholders of Bubs Australia (ASX: BUB) reveled in every small cap investors’ dream over the weekend – a direct shoutout from the President of the United States. And this morning the President issued a follow-up that will renew shareholders’ excitement – it might not quite get the attention of an incendiary ex President Trump tweet,

    Read More
    Public
  • The Cancer Index: Why investing in oncology biotechs is more science than art

    Despite what it may look like, investing in biotechs is more science than art. The sector holds intrinsically higher risk, but investing in it can be well worth it to those willing to take the plunge. In fact, over the last twenty years biotech firms have outperformed the S&P 500 and both the medtech andRead More
    Public
  • Phase II begins for FirstWave’s cyber defence platform

    Cyber crimes worldwide have been getting worse as the internet gets better, with reports from the national cybersecurity agency in Australia reporting cybercrimes increasing 13% in 2021, with an incident occurring on average every 8 minutes. As new attack methods and vectors, and the use of sophisticated AI evolve, the average business loss from email

    Read More
    Public
  • Forget the details, Mighty Kingdom has just inked a deal with Google

    Gaming company Mighty Kingdom (ASX: MKL) has partnered with some of the world’s most recognised brands like LEGO, Disney and now Google, with the Company today announcing a new contract. Google will work with Mighty Kingdom for an upcoming technology partnership under a fixed term six month ‘work for hire’ agreement. Any description of the

    Read More
    Public
  • Envirosuite’s machine learning wastewater tech ahead of schedule, accelerates growth

    Environmental intelligence company Envirosuite (ASX: EVS) has provided a promising update on its newest product, EVS Water, which has picked up new customers in Australia, Asia , Europe and the US with revenues ahead of originally forecast. The technology is close to achieving its initial goal of $1m in total sales, only one year into

    Read More
    Public